Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ivermectin vs Ivermectin + Albendazole for Onchocerciasis
NCT02078024Phase 3Completed
- Sponsor
- University Hospitals Cleveland Medical Center
- Start
- Jun 2014
- Primary completion
- Jun 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of albendazole in onchocerciasis, sponsored by University Hospitals Cleveland Medical Center. Started Jun 2014; status: completed.
02
Drugs
albendazole
03
Conditions
onchocerciasis
Beyond the preview
Go deeper on NCT02078024.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02078024.